Syringe with patient-contacting surface - Patents.com

The syringe's innovative hub design with a center post and collar controls cannula penetration depth and force distribution, addressing inconsistent injection depths and discomfort in existing devices.

JP7584462B2Active Publication Date: 2024-11-15BECTON DICKINSON & CO
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
JP2022016465
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2016-04-08
Filing Date
2022-02-04
Publication Date
2024-11-15
Estimated Expiration
2037-04-07

AI Technical Summary

Technical Problem

Existing injection devices lack effective control over the depth of cannula penetration into the skin, leading to inconsistent drug delivery and potential discomfort due to varying angles of injection.

Method used

A syringe design featuring a needle hub with a center post and an outer collar, where the dimensions and positioning of these components create a controlled skin-contacting surface to manage cannula penetration depth and distribution of insertion force.

Benefits of technology

The syringe provides controlled cannula penetration depth, reducing discomfort and ensuring consistent drug delivery by distributing insertion force over a larger skin area, enhancing user comfort and injection precision.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007584462000001
    Figure 0007584462000001
  • Figure 0007584462000002
    Figure 0007584462000002
  • Figure 0007584462000003
    Figure 0007584462000003
Patent Text Reader

Abstract

To provide a syringe having a needle hub capable of controlling the penetration depth of a cannula [Solution] a syringe barrel for receiving a plunger; a post extending axially from a distal end of the syringe barrel; a cannula received within an axial passage in the post and extending from the distal end of the syringe barrel; and an outer annular collar surrounding the post and extending axially from the distal end of the syringe barrel, the collar defining an annular recess between the post and the collar, the collar having a distal end face positioned a distance relative to the distal end face of the post for contacting the skin upon insertion of the cannula into a patient's skin, whereby the distal end face of the collar and the distal end face of the post contact the skin and provide controlled deformation of the skin for inserting the cannula to a selected depth.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention is in the field of injection medical devices for delivering drugs or medications to a patient. Specifically, the present invention is directed to a syringe or pen needle having a needle-bearing hub with a patient-contacting surface for improved injection performance. The patient-contacting surface is configured to facilitate a desired depth of penetration of the cannula into the skin. The hub can be integral with the syringe barrel or can be mounted on a medication pen used to administer the medication, but is not limited to use with such devices. [Background technology]

[0002] Medication pens for delivering self-administered medications generally include a syringe or pen body that houses a medication compartment, and a separate pen needle that may be attached to or detached from the pen body. The syringe or pen needle includes a needle-bearing hub with a proximal recess for receiving the pen body, and a proximal (non-patient end) needle that accesses the medication compartment and typically pierces a septum of a medication cartridge within the pen body. The distal (patient end) of the pen needle assembly includes a beveled distal end of the needle that is inserted into the injection site.

[0003] Injections may be performed in the intradermal (ID), subcutaneous (SC) and intramuscular (IM) regions. For many types of injectable drugs, including insulin, the SC region is preferred for administering injections. See, for example, Lo Presti et al., J. Immunol. 1999, 143:1311-1323, 1999.

[0004] Needles of different lengths, and frequently shorter needles such as 4mm and 5mm needles, are suitable for achieving injections to a particular target depth within the subcutaneous region. The present invention addresses the need to ensure that the needle is inserted to that target depth regardless of the angle at which a user may approach the injection site with a medication pen.

[0005] In some prior art pen needles, the cannula is supported within an axially positioned post on the hub. The post forms a narrowed portion extending distally from a relatively wide portion in which the pen body is received. In other pen needles known in the art, the distal face of the hub that rests against the injection site may be relatively large and may include a slight taper at the edge. However, the edge of the hub engages the skin when the cannula is inserted at an angle interfering with the injection.

[0006] While the prior art devices are generally adequate for their intended uses, there continues to be a need for improved devices for controlling the penetration of a cannula for delivering a drug or agent. [Prior art documents] [Non-patent literature]

[0007] [Non-Patent Document 1] Skin and subcutaneous thickness at injecting sites in children with diabetes: ultrasound findings and recommendations for giving injection, Pediatric Diabetes (2012). Summary of the Invention [Means for solving the problem]

[0008] The present invention relates to injection devices, and in particular to syringes having a needle hub with a skin contacting surface configured to control the depth of penetration by a cannula extending from the needle hub. The present invention is particularly directed to a needle hub device in which the contacting surfaces have complementary heights and widths to provide sufficient surface area to control the depth and shape of indentation in the skin under normal insertion forces, thereby controlling the depth of cannula penetration.

[0009] The syringe of the present invention has a needle hub with a center post for supporting a cannula and an outer collar or ring surrounding the post. In one embodiment, the syringe is configured to dispense small doses of contents ranging from about 0.3 ml to 0.5 ml, although the volume may vary depending on the intended use of the injection device. In other embodiments, the syringe can deliver a volume of about 1 ml to 3 ml. The outer collar has dimensions for contacting the surface of the skin during injection under typical insertion forces to control the penetration of the cannula into the skin. The post has a distal end that can be positioned relative to the distal end of the collar to provide control of the depth of penetration of the cannula. The post can be positioned substantially flush with the distal surface of the collar. In other embodiments, the distal end of the post can be spaced a distance axially outward from the distal surface of the collar such that the distal surface of the post and the distal surface of the collar form a contact surface for contacting the skin and providing a shape and contour to control deformation of the skin as the cannula penetrates the skin during use. The dimensions and location of the post relative to the collar provide a skin contact surface with dimensions that distribute forces across the skin surface to reduce the occurrence of the cannula penetrating the skin deeper than intended.

[0010] In one embodiment, the syringe hub has a distal face with a diameter ranging from 2.0 mm to 8.0 mm. The distal face of the post can extend beyond the distal face of the collar, such that the distance between the distal face of the post and the distal face of the collar is about 1.0 mm to about 5.0 mm, and generally about 0.3 mm to about 2.0 mm. In other embodiments, the distal face of the post can protrude from the distal face of the collar a distance of about 0.3 mm to 0.7 mm. In one embodiment, the distal end of the post can be substantially flush aligned with the distal end of the outer collar or recessed with respect to the collar.

[0011] Another aspect of the invention is a syringe having a needle hub defining a substantially convex skin contact surface defined by a post and an outer collar. The contact surface in one embodiment is approximately 0.3 mm to 0.7 mm in height and 1-4 mm in width. 2 may have a surface area of

[0012] One feature of the present invention is to provide a syringe having a center post for supporting a cannula and an outer collar surrounding the post, the distal end of the post being recessed approximately 0.3 mm to 0.7 mm relative to the distal surface of the collar. The hub can have a diameter or width of approximately 2.0 mm to 8.0 mm to provide sufficient surface area and suitable shape to provide a controlled depth of penetration into the skin by the cannula. The distance between the distal surface of the post and the distal surface of the collar allows the patient's skin to enter the recess defined by the recessed post where the skin contacts the surface of the post and collar.

[0013] The shape of the syringe needle hub provides a larger surface area to contact the patient's injection site and control the depth of cannula penetration and reduce the occurrence of excessive cannula penetration as compared to conventional syringe needle hubs. Greater patient comfort and reliability is realized as a result of the larger surface area in contact with the skin during injection.

[0014] Various aspects and features of the present invention are obtained essentially by providing an integral syringe including a syringe barrel having an open proximal end configured to receive a plunger, and a distal exit end. A post extends axially from said distal end of the syringe barrel, the post having an axial passageway in communication with a cavity of the syringe barrel. A cannula is received within the axial passageway of the post and extends from the distal end of the syringe barrel, the cannula having a beveled distal end for injecting into the skin of a subject. An outer annular collar surrounds the post and extends axially from the distal end of the syringe barrel and defines an annular cavity between the post and the collar, the collar having a distal end positioned relative to the distal end of the post for contacting the skin upon insertion of the cannula into the skin of a patient.

[0015] A further feature of the invention is obtained by providing a syringe including a syringe barrel having a drug compartment, a proximal end having a plunger, and a distal end having a hub. The hub has a distal annular surface and an axially extending post with an axial passageway for receiving a cannula and communicating with the drug compartment. An axially extending annular collar surrounds the post and has a distal annular surface. The distal annular surface of the post and the distal annular surface of the collar are configured to provide a skin contacting surface for controlling deformation of a patient's skin when contacted with the skin under normal insertion forces and for controlling the depth of penetration upon insertion of said cannula into a patient.

[0016] It will be understood that each of the preferred or optional features of the various embodiments may be combined with other features, and that features described in combination with one or more particular features may also be combined with one or more features of the other embodiments. These and other features of the invention will become apparent from the following detailed description of the invention, which, in conjunction with the drawings, discloses various embodiments of the invention.

[0017] Below is a brief description of the drawings. [Brief description of the drawings]

[0018] [Figure 1] FIG. 1 depicts a standard syringe barrel with a needle hub protruding from the end of the syringe barrel. [Diagram 2] FIG. 2 is a cross-sectional view of the needle hub of FIG. [Diagram 3] FIG. 2 is a perspective view of a syringe in a first embodiment of the present invention showing a post substantially flush with the end of the collar. [Figure 4] FIG. 4 is an enlarged partial perspective view of the syringe hub of FIG. 3. [Diagram 5] FIG. 4 is a cross-sectional view of the syringe hub of FIG. [Figure 6] 4 is a cross-sectional view of the syringe hub of FIG. 3 deforming the skin upon penetration of the cannula. [Figure 7] FIG. 13 is a cross-sectional view of a modified syringe hub. [Figure 8] FIG. 13 is a perspective view of a syringe hub in another embodiment of the present invention. [Figure 9] FIG. 9 is a cross-sectional view of the syringe hub of FIG. [Figure 10] 9 is a cross-sectional view of the syringe hub of FIG. 8 showing deformation of the skin during penetration of the cannula. [Figure 11] FIG. 13 is a perspective view of a syringe hub in another embodiment of the present invention. [Figure 12] FIG. 12 is a cross-sectional view of the syringe hub of FIG. [Figure 13] FIG. 13 is a cross-sectional view showing cannulation into the skin and deformation of the skin. [Figure 14] FIG. 13 is a perspective view of another embodiment of a syringe device. [Figure 15] FIG. 15 is a side view of the syringe of FIG. 14. [Figure 16] FIG. 15 is a cross-sectional view of the syringe of FIG. 14. [Figure 17] FIG. 15 is a top end view of the syringe of FIG. [Figure 18] FIG. 15 is a bottom end view of the syringe of FIG. 14. [Figure 19]FIG. 13 is a cross-sectional side view of a syringe in a further embodiment. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0019] A syringe is used herein to refer to a device having a drug compartment and a cannula for delivering a drug, such as insulin, to a patient. A pen delivery device typically contains multiple doses of drug and a separate pen needle. The expression "pen needle" refers to a needle assembly that can be attached to a drug pen body such that the proximal end of the pen needle assembly accesses the drug compartment and the distal end is suitable for insertion into an injection site to perform one or more injections. The terms "needle" and "cannula" can be used interchangeably herein. In one embodiment, a cannula can be a member configured for insertion into an injection site of a subject. One example is a cannula with a beveled end for insertion into a patient. As used herein, the "distal" direction is the direction toward the injection site and the "proximal" direction is the opposite direction. "Axial" means along or parallel to the longitudinal axis of the needle, and the "radial" direction is the direction perpendicular to the axial direction.

[0020] The location of the subcutaneous layer within the subject's tissue and the desired injection depth will vary depending on the patient's age, the part of the body to which the injection is administered, etc. Thus, the absolute injection depth is not considered a critical aspect of the present invention. Generally, the intradermal (ID) layer in an adult has a thickness of approximately 2 mm to 3 mm, so the ID injection depth is in the range of about 3 mm or less, the depth being measured from the outer surface of the skin. The thickness of the subcutaneous (SC) region varies greatly depending on the location of the injection site on the subject's body and the subject's body mass index (BMI). The average thickness of the SC space is in the range of about 7 mm to about 12 mm, so the SC injection depth is in the range of about 3 mm to 15 mm. The SC region may be further subdivided into a shallow subcutaneous (SSC) layer having a thickness of about 1 mm and an injection depth of about 2 mm to about 4 mm, an SC layer having a thickness of about 4 mm with a depth of about 3 mm to 7 mm, and a deep subcutaneous (DSC) layer having a thickness of about 4 mm and a depth of about 7 mm to about 12 mm. When an injection from a device occurs in the upper region of the subcutaneous space (SSC), the device is likely to be used for ID injection. When an injection from a device occurs in the deeper region of the subcutaneous space (DSC), the device is likely to be used for IM injection. Insulin is preferably delivered to the SC space. Injection into either the ID or intramuscular (IM) space may result in insulin uptake different from that prescribed.

[0021] The present invention is directed to an injection device, and in particular a syringe having a cannula with a predetermined length for penetrating the skin to a predetermined penetration depth. The injection device has a skin contact surface for contacting and deforming the skin as the cannula penetrates the skin to help control the depth of penetration at various angles of injection relative to the surface of the skin. The contact surface has a predetermined shape, width, and height for controlling the depth of penetration into the skin to a desired layer of the skin. In one embodiment, the contact surface having a diameter of about 3-4 mm provides a sufficient surface or contact area to prevent deep indentation in the skin around the cannula when the device is pressed against the skin by a typical insertion force during use. The syringe can be, for example, a 0.3 ml syringe or a 0.5 ml syringe, although larger sizes can be provided depending on the drug being dispensed.

[0022] 1 and 2, a commonly used syringe barrel 10 has a hub 12 with a post 14 that projects outwardly from an annular ring 16. The end face of the post is positioned from the outer ring 16 such that during normal use, only the end of the post contacts the skin during insertion of the cannula. The end face of the post has dimensions such that a deep indent is typically formed in the skin by the post in contact with the skin. The deep indent formed in the outer surface of the skin often results in the cannula penetrating deeper into the skin, to a deeper skin layer than intended by the user. By way of example, a 4.0 mm cannula seated in a post having a width of about 1 mm may result in a contact surface that forms a deep concave indentation in the surface of the skin, such that the cannula may penetrate deeper than 4 mm and may penetrate a deeper layer of the skin, which may cause pain or discomfort to the user. Deeper penetration can also result in the cannula for delivering drugs to the skin layer being less effective at delivering drugs to the patient and can increase the risks of intramuscular injections, especially in pediatric patients.

[0023] In the present invention, the skin contact surface of the syringe hub surrounding the cannula has a width and height configured to provide a larger surface area and greater control of the depth of penetration by the cannula. In one embodiment of the present invention, the pen needle device is configured to obtain a cannula penetration of about 4 mm. The skin contact surface is further configured to control the shape, width and depth of deformation of the skin surface when the device is pressed against the skin during cannula penetration. The width is determined to be the surface area defined by the outer periphery that contacts the skin during cannula insertion and during injection or delivery of a drug using normal insertion force. The height refers to the linear distance between the outer periphery of the contact surface and the proximal end of the contact surface.

[0024] The skin contact surface in one embodiment of the invention may have a substantially convex shape, a substantially flat surface or a concave surface that contacts the skin during cannula penetration and drug delivery. The contact area may have a width or diameter of greater than 3.0 mm and typically about 4.0 mm. The contact area in one embodiment may have a substantially annular or circular shape. The width of the contact area refers to the diameter or transverse dimension of the perimeter as shown by arrow 59 in FIG. 5. The contact area may be coplanar or may have a height or depth of about 0.5 mm to about 1.5 mm measured from the perimeter edge of the contact surface to the contact surface of the post.

[0025] In the embodiment of Figures 3-7, syringe 20 includes a syringe barrel 22 having an open proximal end 24 and a distal end 26. An internal axial cavity 28, shown in Figure 5, receives a medication to be delivered to a patient. The open proximal end 24 receives a plunger 30 for dispensing the contents of the syringe. A hub 32 extends axially from the distal end 26 to support a cannula 34 and define a skin contact area.

[0026] The hub 32 shown in Figures 4 and 5 has an axially extending center post 36 for supporting the cannula 34. As shown in Figure 5, the post 36 has an axial passage 38 that communicates with the cavity 28 of the syringe barrel 22. The cannula 34 is mounted within the axial passage 38 and attached by a suitable adhesive 40, as shown in Figure 5. The cannula 34 has a longitudinal length for penetrating the skin to a desired depth. The distal end of the axial passage 38 has a conical shape that flares outwardly toward the periphery of the post to define a recess 42 for receiving the adhesive 40. In the embodiment shown, the adhesive 40 fills the conical recess 42 such that the axial end of the post is substantially flat and the adhesive does not seep outwardly from the face of the post 36. The distal end face 44 of the post 36 in the embodiment shown has a substantially flat surface oriented in a plane substantially perpendicular to the longitudinal axis of the syringe and the cannula 34. Distal end face 44 in the embodiment shown has an annular configuration and a narrow radial width relative to the diameter of post 36. Adhesive 40 fills recess 42 such that the adhesive is substantially flush with the periphery of post 36 to form a flat distal surface 46 for contacting the skin during insertion of the cannula into a patient.

[0027] The hub 32 includes an outer annular collar 48 that forms a sleeve or ring that surrounds the post 36. The collar 48 is concentric with the post and spaced radially outward from the post 36 to define an annular recess 50. In the embodiment shown, the annular recess 50 extends from the proximal end of the collar 48 and the proximal end of the post 36, as well as between the outer surface of the post 36 and the inner surface of the collar 48. The radial dimension of the annular recess 50 can be about 0.5 mm to 3 mm, and typically about 1.0 mm.

[0028] The collar 48 has a distal face 52 that forms an annular shaped skin-contacting surface spaced outwardly from the distal surface of the post 36. In the embodiment shown, the distal face 52 is substantially flat and coplanar with the plane of the distal face 44 of the post 36. The distal face 52 has a slightly rounded periphery 53 to provide a level of comfort to the patient during use. The distal face 44 of the post 36 and the distal face 52 of the collar 48 define the skin-contacting surface when the cannula is inserted into the patient. The distal face 52 of the collar 48 defines the outer dimensions of the skin-contacting surface. The orientation and dimensions of the collar 48 are provided to contact the patient's skin under typical insertion and injection forces and to distribute the forces over an area to control the depth of penetration of the cannula into the skin.

[0029] 6, the cannula 34 is inserted into the patient to penetrate the skin to a desired depth. The collar 48 has a diameter to distribute or spread the penetration force over a larger surface area of ​​the skin to limit inward deformation or indentation of the skin compared to prior art syringes in which only the post supporting the cannula engages the skin forming a deep depression or indentation in the skin resulting in deep cannula penetration. The distal surface 44 of the post 36 and the distal surface 52 of the collar 48 define a substantially flat contact surface to distribute the force over a sufficient surface area to control the depth of the indentation formed by the penetration force as shown in FIG.

[0030] Initial cannula penetration by contact of the hub protruding from the syringe barrel with the patient's skin creates a skin indentation and an initial cannula penetration depth. The surface of the skin then relaxes as shown in Figure 6, so that the surface of the skin substantially conforms to the shape of the contact surface and limits the depth of cannula penetration. The present invention relates to the shape, surface area and height of the contact surface to provide control of the cannula penetration depth and the penetration force applied to the injection device during injection.

[0031] The cannula in the illustrated embodiment may have a length of about 4.0 mm to 6.0 mm to penetrate the skin to a desired depth for efficient delivery of drugs, and insulin in particular. In other embodiments, the cannula may have a length of about 3.5 mm to about 8.0 mm. In yet further embodiments, the cannula may have a length of about 2.5 mm to 6.0 mm, and generally about 4.0 mm to 5.0 mm. The cannula may be, for example, 31 gauge or 32 gauge, although other gauges may be used. The contact surface of the hub has a width and height that controls the deformation and size of the indentation in the skin, as well as distributes the injection force over a sufficient area, thereby controlling the depth of penetration of the cannula. The shape and dimensions of the contact surface distribute the pressure applied upon full engagement with the skin surface. The contours combine with the pressure distribution to provide improved comfort to the patient. The height and surface area of ​​the hub as well as the perimeter surface area affect the degree of tissue compression and relaxation for a given actuation force.

[0032] The dimensions of the hub may vary depending on the desired cannula penetration depth and cannula length. The collar has an axial length indicated by arrow 58. The collar may have a length of about 5.0-7.0 mm, and typically about 6 mm. The collar may have a diameter of about 4.0 mm to 10.0 mm, generally about 3.0-5.0 mm, and typically about 4.0 mm, indicated by arrow 59. The post 36 may have a diameter of about 1 / 3 the outer diameter of the collar. The post may have a diameter of about 1.0 mm to 2.0 mm.

[0033] 7, the post 36 may have a deep recess 54 at the distal end of the axial passage 38 for receiving adhesive and securing the cannula 34 to the post. In this embodiment, the recess 54 is deep enough to allow the adhesive 40 to be recessed relative to the distal end of the post and form a recess 56 around the cannula 34.

[0034] 8-10 show an alternative embodiment of a syringe 60 having a syringe barrel 62 and a hub 64 for supporting a cannula 66. The hub 64 is formed by a center post 68 and an outer collar 70. As in the previous embodiment, the post 68 has a substantially cylindrical shape extending axially from the distal end of the syringe barrel. The post 68 has an axial passage 72 for receiving the cannula 66 and adhesive 74 for securing the cannula 66 to the post 68. The distal end of the post and adhesive 74 define a distal face of the post for contacting the skin during insertion of the cannula into a patient. In the embodiment shown, a rib 69 extends between the center post 68 and the outer collar 70 for stabilizing the post 68 and the cannula 66. As shown, the rib 69 has a distal end spaced inwardly from the distal end of the post 68.

[0035] The collar 70 has a cylindrical shape surrounding the post and extending from the distal end of the syringe barrel to define an annular recess 71. The annular recess 71 may have a radial width of about 1-3 mm. The collar 70 has a distal surface 76 that forms an annular skin contact surface. In the embodiment shown, the distal surface 76 has a substantially flat contact surface that is oriented in a plane parallel to the plane of the distal face of the post and substantially perpendicular to the longitudinal axis of the cannula. The collar has a rounded or curved outer periphery 77 to form a smooth transition between the distal face and the side of the collar. The distal surface 79 of the post 68 is recessed with respect to the distal surface 76 of the collar to form a slight recess 81. As shown in FIG. 10, the recess 81 formed by the position of the distal surface of the post 68 relative to the distal surface of the collar 70 allows the patient's skin 83 to deform into the recess 81 during insertion of the cannula into the patient's skin. The distal surface of the post and the distal surface of the collar form a skin contacting surface and have a radius to define a surface area to control the depth of indentation in the skin under insertion force. Figure 10 shows the deformation of the skin during insertion of the cannula where the indentation in the skin substantially follows the shape of the contacting surfaces of the post and collar.

[0036] In one embodiment, the axial spacing between the distal face 76 of the collar 70 and the distal face 79 of the post 68 can be about 1.0 mm to 1.5 mm, and generally about 0.3 mm to 0.7 mm. The axial spacing between the distal face 76 of the collar 70 and the distal face 79 of the post 68 defines the depth of the recess 81. The diameter of the inner edge of the collar 70 defines the width of the recess 81.

[0037] 11-13 show another embodiment of a syringe 80 having a syringe barrel 82 and a hub 84 supporting a cannula 86. The hub 84 has a center post 88 for receiving the cannula 86 and a cone-shaped recessed end for receiving adhesive 90. As in the previous embodiment, the adhesive fills the recess in the end of the post 88 to form a substantially flat distal surface 92 of the post 88. An outer collar 94 surrounds the post 88 to define an annular recess 96 between the post 88 and the collar 94. The annular recess 96 may have a radial width extending between the inner surface of the collar 94 and the outer surface of the post 88 of about 0.5 mm to 3.0 mm, and typically about 1.0 mm.

[0038] In the embodiment of FIG. 12, the post 88 has an axial length that is greater than the axial length of the collar 94, such that the distal surface 92 of the post 88 is spaced axially outward from the distal surface 96 of the collar. As shown in FIG. 13, the post 88 is spaced a distance from the collar, such that the distal surface of the post and the distal surface of the collar define a skin contacting surface during insertion of the cannula. As shown in FIG. 13, the distal surface of the post creates a depth of the resulting indentation that is greater than the depth of the collar and provides a smooth substantially concave curvature of the skin indentation. Skin deformation is caused by insertion forces during insertion and penetration of the cannula with the insertion forces normally applied by the patient. In one embodiment, the distal surface 92 of the post 88 extends axially a distance of about 0.3 mm to 0.7 mm from the distal surface of the collar 94. In the embodiment shown, the post 88 and collar 94 form a substantially convex curved skin contacting surface. The post 88 may extend a distance from the collar to provide a skin-contacting surface having a radius of curvature of, for example, about 6.0 mm to 10.0 mm.

[0039] The distal contact surface of the hub can have a variety of configurations to provide the desired control over the depth of penetration of the cannula. In each embodiment, the distal contact surface has a width or diameter to provide sufficient surface area and height, defined by the curvature of the contact surface, to minimize depressing the skin that could cause the cannula to penetrate the skin deeper than intended.

[0040] In various embodiments, the post may have a diameter of about 1.0 to 3.0 mm, and typically about 1.0 to 1.5 mm. The post may have a height of about 1.0 to 1.5 mm, as measured from the circumference of the contact surface of the collar. The ratio of the post diameter (D) to the axial spacing between the distal surface of the post and the distal surface of the collar may range from about 2:1 to about 4:1, and typically about 2.5:1 to 3:1. A larger ratio provides a larger surface area, providing greater comfort to the patient and enhanced control of insertion depth.

[0041] 14-18, a further embodiment of an injection device is shown including a syringe barrel 100 having a distal end 102 and a proximal end 104. The distal end 102 is similar to the embodiment of FIGS. 2-6 and includes an outer collar 106, an inner post 108, and a rib 110 extending radially between an inner surface of the outer collar 106 and an outer radial surface of the post 108. As shown in FIG. 16, the rib 110 has a distal end 112 spaced apart from an end of the collar 106 and an end of the post 108. In this embodiment, the collar 106 has an annular distal surface 114 oriented in a plane substantially perpendicular to the longitudinal axis of the syringe barrel 100. The inner post 108 has a distal annular surface 116 oriented in a plane substantially perpendicular to the longitudinal axis of the syringe barrel. In the embodiment shown, a distal face 116 of the post 108 is oriented coplanar with the distal face 114 of the collar 106. A longitudinal passage 118 extends through the post 108 for receiving and supporting a cannula 122 and communicating with the interior chamber 120 of the syringe barrel 100. The cannula 122 is attached to the post 106 by an adhesive, as in the previous embodiment, and has a length and width, as in the previous embodiment.

[0042] The proximal end 104 of the syringe barrel 100 has an open end 124 for receiving a plunger (not shown) for dispensing the contents of the chamber 120 in the usual manner. In the embodiment shown, the proximal end 104 of the syringe barrel 100 has an axially extending collar 126 for receiving the operating end of the plunger.

[0043] Flanges 128 extend radially outward from opposite sides of the proximal end 104 between the syringe barrel 100 forming finger grips or finger flanges for a user to manipulate the device and deploy the plunger during use. In one embodiment, as shown in FIG. 15, the flanges 128 are substantially identical and mirror images of one another and extend outward for gripping the device by a user. In other embodiments, the flanges may be asymmetric with different shapes, sizes, and orientations to provide a desired tactile feel to aid the user in gripping and manipulating the device. The flanges 128 have a distal surface 130 and a proximal surface 132. In the embodiment shown, the flanges 128 curve away from the distal end of the syringe barrel 100 to form a substantially concave surface of the proximal surface 132. In an alternative embodiment, the flanges may curve in the opposite direction toward the distal end of the syringe. As shown, flange 128 has a curvature to provide an ergonomic grip and unique feel to conform to the user's fingers for increased comfort of use. The ergonomic shape and conformation of flange 128 provides increased comfort and tactile confirmation that makes holding and handling the syringe easier for people with dexterity issues such as arthritis and neuropathy, which can occur in diabetics. In other embodiments, one or both flanges may be curved toward the distal end or may be straight and substantially flat.

[0044] In one embodiment, the flange 128 is provided with tactile structures to assist the user during plunger deployment and substance delivery. The tactile structures may be present on one or both flanges, and on either or both of the distal and proximal surfaces. In the embodiment shown, a dimple 134 is formed in the flange 128 so as to extend from the proximal surface of the flange. In the embodiment shown, the dimple 134 is oriented toward the outer edge 136 of the flange 128 forming a smooth curved portion 128 between the dimple 134 and the collar 126. In other embodiments, the dimple may be positioned in the center or elsewhere on the flange surface(s). The dimple 134 in the embodiment shown has a substantially convex, dome-shaped, teardrop shape, with the outer edge 138 of the dimple formed at the outer edge 136 of the flange 128. Alternatively, the dimple may have other shapes, such as a rounded or elliptical shape. The dimples 134 have a width, length, and height sufficient to provide a tactile feel to assist the user in positioning and gripping the syringe. In other embodiments, the dimples or other tactile members may be spaced inwardly from the ends of the flanges and in other suitable orientations. In one embodiment, the dimples extend the width or length of the flange and may be provided on one or both surfaces of the flange.

[0045] Ridges 140 may be provided on the faces of the dimples 128 to provide additional tactile feel. In the embodiment shown, the ridges extend across the exterior surface of the dimple 134 and are positioned toward the outer edge relative to the convex surface of the dimple 134. The ridges may be oriented to extend radially outward on the outer and / or inner surfaces of the dimple. In other embodiments, instead of protruding ridges, recesses or other tactile structures may be provided on the dimples.

[0046] The dimple 134 forms a concave recess 142 on the distal surface 130 of the flange 128, as shown in FIG. 18. The recess 142 may also have one or more ridges or recesses in the surface to provide a tactile feel. A substantially U-shaped aperture 144 is formed along the outer edge to form a recess along the outer edge 136 to provide a tactile feel to the user. A protruding detent 146 is formed in the concave surface of the recess 142 that protrudes toward the distal end of the syringe barrel 100. As shown in FIGS. 16 and 18, a ridge 148 may be formed adjacent the detent 146 to extend across the width of the concave recess 142. The detent 146 and ridge 148 provide an additional tactile feel to the user to aid in gripping and positioning the syringe barrel. In other embodiments, the ridge may be provided to extend across the entirety of the proximal surface, the distal surface, or both the distal and proximal surfaces.

[0047] In the embodiment shown, the dimples protrude from the proximal surface. In alternative embodiments, the dimples may protrude from the distal surface to form a recess on the proximal surface. In other embodiments, other tactile structures or members may be provided on the proximal and / or distal surfaces to aid the user in positioning and manipulating the syringe. In a further embodiment shown in FIG. 19, the flange 128 curves toward the distal end of the syringe. Elements of the embodiment of FIG. 19 are identified by the same reference numbers for consistency. In the embodiment of FIG. 19, a dimple 140 is shown protruding from the distal surface of the flange toward the distal end of the syringe. A recess 136 is shown formed on the proximal surface of the flange. In further embodiments, a dimple or other tactile member may protrude from the proximal surface of one or both flanges, or from the distal surface of one or both flanges. Similarly, one or more recesses may be formed on one or both flanges, on the proximal surface, the distal surface, or on both the proximal and distal surfaces.

[0048] The dimple 134 in the flange 128 is shown in connection with an embodiment in which the inner post 108 has an axial length substantially the same as the axial length of the collar 106. The dimple 134 may also be included in the embodiments of Figures 3-7 and 8-10 in which the post 68 has an axial length less than the axial length of the collar 70, and in the embodiment of Figures 11-13 in which the post 88 has an axial length greater than the axial length of the collar 94, to provide a desired tactile feel to the syringe during use.

[0049] The above description of the preferred embodiment should not be considered as limiting the invention defined by the appended claims. The disclosure is intended to enable those skilled in the art to make the described variations of the invention without departing from the scope of the invention. In this specification and claims, numerical limitations are understood to be limited by the modifier "about", so that minor departures producing equivalent results are within the scope of the invention. Features or limitations of dependent claims disclosed in connection with one embodiment or independent claim may be combined in another embodiment or with different dependent claims without departing from the scope of the invention.

Claims

1. a syringe barrel having an open proximal end configured to receive a plunger, and a distal exit end; a post extending axially from a distal end of the syringe barrel, the post having an axial passageway in communication with a cavity of the syringe barrel and having a distal end face; a cannula received within the axial passage of the post and extending from the distal end of the syringe barrel, the cannula having a distal end for injection into the skin of a subject; an outer annular collar surrounding the post and extending axially from the distal end of the syringe barrel and defining an annular recess between the post and a collar, the collar having a distal end surface positioned a distance relative to the distal end surface of the post for contacting the skin upon insertion of the cannula into a patient's skin, whereby the distal end surface of the collar and the distal end surface of the post contact the skin and provide a controlled deformation of the skin for inserting the cannula to a selected depth; Including, the distal end surface of the post and the distal end surface of the collar are aligned on a continuous convex curve having a radius of curvature of about 6.0 mm to about 10.0 mm; The one-piece syringe, wherein the distal end surface of the post and the distal end surface of the collar define a skin contacting surface having a diameter of about 3.0 to 4.0 mm.

2. 2. The syringe of claim 1, wherein the distal end surface of the post and the distal end surface of the collar have widths that distribute insertion forces across the skin to control the depth of penetration of the cannula.

3. 2. The syringe of claim 1, wherein the distal end face of the post is spaced axially outwardly a distance from the distal end face of the collar, whereby the distal end face of the post and the distal end face of the collar define a skin contacting surface.

4. 2. The syringe of claim 1, wherein the cannula has a length extending from the post of about 3.5 mm to about 8.0 mm.

5. 2. The syringe of claim 1, wherein the distal end face of the post has a radial width for contacting a surface of the skin during insertion of the cannula into a patient's skin, and the distal end face of the collar is axially positioned relative to the distal end face of the post, whereby the distal end faces of the post and the distal end faces of the collar form a skin contacting surface comprising a configuration for distributing insertion forces and controlling deformation of the skin upon insertion of the cannula into a patient.

6. 2. The syringe of claim 1, wherein the distal end face of the post is substantially flat and oriented in a plane substantially perpendicular to a longitudinal axis of the syringe barrel.

7. 2. The syringe of claim 1, wherein the distal end surface of the collar is substantially flat and has an outer edge with a convex rounded profile, the substantially flat distal end surface of the collar extends between the outer edge and an inner edge, and the substantially flat distal end surface of the collar is substantially parallel to the substantially flat distal end surface of the post.

8. 2. The syringe of claim 1, wherein the axial passage of the post has a cone-shaped recess at the distal end of the post, and adhesive is received within the recess for attaching the cannula to the post, and the adhesive is substantially flush with the distal end surface to form a flat end surface.

9. 10. The syringe of claim 1, wherein the syringe barrel includes at least one flange extending radially outward from a proximal end of the syringe barrel for gripping by a user, the flange having a proximal surface with at least one tactile member and a distal surface with at least one tactile member.

10. 10. The syringe of claim 9, wherein the tactile member on the proximal surface of the flange is a dimple that protrudes outwardly from the proximal surface, and the tactile member on the distal surface is a recess.

11. The syringe of claim 10, wherein the at least one recess in the distal surface includes a protruding detent.

12. 2. The syringe of claim 1, wherein the post has an outer diameter of 1.0 to 2.0 mm.

13. 2. The syringe of claim 1, wherein the distal end face of the post is spaced axially outward from the distal end face of the collar a distance of about 0.3 to 0.7 mm.

14. 2. The syringe of claim 1, further comprising at least one flange extending radially outward from a proximal end of the syringe barrel for gripping by a user, the flange having a proximal surface with at least one tactile member formed by a protruding dimple and a proximal surface with a tactile member formed by a recess having a distally protruding detent opposite the protruding dimple.

15. 2. The syringe of claim 1, wherein the collar has an outer diameter less than an outer diameter of the syringe barrel.

Citation Information

Patent Citations

  • Pen needle hub having increased contact area

    JP2009090098A

  • Prefilled syringe

    JP2011212184A

  • Pen needle assembly for drug delivery

    JP2012519546A

  • Injection pressurizer

    US20120296370A1

  • Pen needle HUB with a patient contact surface

    WO2016123494A1